US GDP Grew at 2 Annual Rate in First Quarter Signaling Economic Resilience Shell SHEL Receives Rating Upgrade Following ARC Resources Transaction SpaceX Scrubs Starship Test Flight Eyes Friday Retry Amid IPO Prospectus Release TSMC Stock Flirts with Buy Point as Chip Giant Plans Price Hike Amid AI Demand Disney Shares Surge 7 as Streaming and Parks Segments Drive Revenue Beat in CEO Josh DAmaros First Earnings Report Mercury Achieves 52 Billion Valuation Following Latest Funding Round Marking 49 Surge in 14 Months BNR Q3 2022 Earnings Narrower Loss Surprises Wall Street as Stock Drops 11 on Broader Biotech Selloff Brixmor Property Group Q1 2026 Earnings Significant EPS Beat Driven by Operational Strength MHK Q1 2026 Earnings EPS Beats Estimates Amidst Challenging Markets BAER Q1 2026 Earnings EPS Miss of 537 with Uptick in Stock Price RILYP Q1 2024 Earnings Preferred Stock Reports Loss Amid Challenging Quarter EDAP Q4 2025 Earnings WiderthanExpected Loss Weighs on Shares Navitas Semiconductor NVTS Surges 1155 as Investor Sentiment Shifts Howmet Aerospace HWM Surges 208 Testing Key Resistance Near 275 Stardust Power Inc SDST Plunges 185 as Selling Pressure Intensifies Zimmer Biomet ZBH Edges Higher as Support Holds Resistance Looms Provident Financial Services Holds Steady Near Support Amid Modest Decline Rafael Holdings Inc RFL Q1 2025 Earnings Net Loss Widens Amid Minimal Operating Revenue Amer Sports Inc Q1 2026 Earnings EPS Beats Estimates by 211 Stock Holds Steady RDWR Q1 2026 Earnings EPS Misses Estimates Stock Declines 298 Kronos Worldwide Inc KRO Q1 2026 Earnings Narrowerthanexpected loss as EPS surprises to the upside BATRA Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Progress BWMX Q1 2026 Earnings EPS Misses Expectations Despite Slight Stock Uptick SpaceX and OpenAI MegaIPOs May Signal Market Peak Analysts Warn PGNY Q1 2026 Earnings EPS Falls Short of Estimates Despite Modest Stock Gain A Paradise Acquisition Corp Unit APADU Holds Steady at 1000 Amid Neutral Trading OGS Q1 2026 Earnings EPS Misses Estimates as Operating Costs Pressure Results ACGL Q1 2026 Earnings Slight EPS Miss Amid Steady Underwriting Performance CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline XRN Q1 2026 Earnings Significant EPS Miss Highlights Ongoing Challenges TLN Q1 2026 Earnings EPS Falls Far Short of Estimates Yet Shares Edge Higher MBINL Q1 2026 Earnings Preferred Shares Beat EPS Estimates as Earnings Surprise Exceeds 5 ASR Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds